2m 2m 2m 2m 2m 2m 2m
Corcept Therapeu (CORT)
NASDAQ
$85.58-$0.32 (-0.37%)
Price as of Jul 13, 2026 7:59 PM EDT- $9.9BMarket Cap
- 18.04%1-Year Change
- BiotechnologyIndustry
Corcept Therapeu (CORT)
$85.58-$0.32 (-0.37%)
CORT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $85.90 | ||
Change | -$5.98 (-6.51%) | ||
Open | $90.30 | ||
High | $91.49 | ||
Low | $84.88 | ||
Previous Close | $91.88 | ||
Volume | 1,325,306 | ||
30-Day Average Volume | 1,064,760 | ||
1-Week Change | -6.23% | ||
1-Month Change | 3.61% | ||
1-Year Change | 18.04% | ||
3-Year Change | 279.75% | ||
5-Year Change | 298.05% | ||
Fundamentals | |||
Shares Outstanding | 107.4M | ||
Total Assets | $814.9M | ||
Market Cap | $9.9B | ||
Enterprise Value | $9.8B | ||
Period: QTR TTM FY | |||
Revenue | $164.9M | ||
Net Income | -$31.8M | ||
Free Cash Flow | -$17.0M | ||
EBIT | -$44.7M | ||
EBITDA | -$44.1M | ||
Net Working Capital | $276.8M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | -221 | ||
Enterprise Value/Revenue | 59 | ||
P/B | 15 | ||
P/E | -306 | ||
PEG | 1 | ||
Price/Free Cash Flow | -581 | ||
Price/Operating Cash Flow | -588 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue